SCHEMBL2687243

SCHEMBL2687243

CC[Si](CC)(COC(=O)c1ccccc1)COC(=O)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.59
ALDH1A1 P00352 3/20 0.55
TDP1 Q9NUW8 3/20 0.53
SLC6A3 Q01959 2/20 0.52
KMT2A Q03164 2/20 0.52
MAPK1 P28482 2/20 0.52
HIF1A Q16665 1/20 0.52
SLC6A2 P23975 1/20 0.52
TSHR P16473 2/20 0.51
SMN1; SMN2 Q16637 4/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
GAA P10253 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
F2 P00734 1/20 0.47
HTR1A P08908 1/20 0.46
CYP2D6 P10635 1/20 0.46
SCN1A P35498 1/20 0.46
SCN5A Q14524 1/20 0.46
SCN2A Q99250 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17520050 0.96 LMNA (0.59) LMNAALDH1A1TDP1SLC6A3KMT2A
SCHEMBL2687492 0.84 LMNA (0.58) LMNAALDH1A1TDP1SLC6A3KMT2A
SCHEMBL29050130 0.81 LMNA (0.58) LMNAALDH1A1TDP1SLC6A3KMT2A
SCHEMBL2689216 0.81 LMNA (0.58) LMNAALDH1A1TDP1SLC6A3KMT2A
SCHEMBL16338679 0.79 LMNA (0.56) LMNAALDH1A1TDP1SLC6A3KMT2A
Ethyl Benzoate SCHEMBL25388294 0.78 LMNA (0.70) LMNAALDH1A1TDP1SLC6A3KMT2A
Ethyl Benzoate SCHEMBL55674 0.78 LMNA (0.70) LMNAALDH1A1TDP1SLC6A3KMT2A
Ethyl Benzoate SCHEMBL2762273 0.78 LMNA (0.70) LMNAALDH1A1TDP1SLC6A3KMT2A
SCHEMBL15070606 0.78 LMNA (0.55) LMNAALDH1A1TDP1SLC6A3KMT2A
SCHEMBL253482 0.77 TDP1 (0.49) LMNAALDH1A1TDP1SLC6A3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222357-B2 Procatalyst composition with multiple internal donor having silyl ester and method UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY LLC (US) 2012-07-17 US disclosed
US-8088872-B2 Procatalyst composition including silyl ester internal donor and method DOW GLOBAL TECHNOLOGIES LLC (US) 2012-01-03 US disclosed
US-20100130710-A1 Procatalyst Composition with Multiple Internal Donor Having Silyl Ester and Method W. R. GRACE & CO.-CONN. 2010-05-27 US disclosed
US-20100130709-A1 Procatalyst Composition Including Silyl Ester Internal Donor and Method W. R. GRACE & CO.-CONN. 2010-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130709-A1 Procatalyst Composition Including Silyl Ester Internal Donor and Method GNE, NANS, ELANE LMNA 1109/4885ALDH1A1 677/4885TDP1 2949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.